+ Reply to Thread
Results 1 to 2 of 2

Thread: Petition: “Do not vaccinate children against COVID-19 until Phase 3 trials are complete”

  1. Link to Post #1
    UK Avalon Member
    Join Date
    11th July 2019
    Age
    54
    Posts
    32
    Thanks
    211
    Thanked 345 times in 31 posts

    Default Petition: “Do not vaccinate children against COVID-19 until Phase 3 trials are complete”

    Mods - if this thread is better placed elsewhere please move

    Below is the response to the petition at https://petition.parliament.uk/petit...l_response=yes

    In my view they have already decided to inject the children and this is just another example of government fobbing off the public.
    I bring it to your attention as it is another example of the "doublethink" that we have endured for so long. First the reassuring tone of how careful they are to ensure the safety of the injections followed by, a little further down the letter, the admission that; "given the absence of safety and efficacy data on COVID-19 vaccines, are not currently recommended for routine COVID-19 vaccination."




    Quote
    Dear ****,

    The Government has responded to the petition you signed – “Do not vaccinate children against COVID-19 until Phase 3 trials are complete”.

    Government responded:

    The Government will continue to evaluate evidence and assess expert opinion before making a decision on routinely vaccinating children under 18 years old.

    No decision has been made by the Government regarding the routine inclusion of children under 18 years within the COVID-19 vaccination programme at a population level. The Government will be guided by the advice of the UK’s independent medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), whose role is to ensure medicines, devices and vaccines work effectively and are safe for use.

    MHRA have now authorised the use of Pfizer/ BioNTech vaccine in children aged 12-15. This follows a rigorous review of the safety, quality and effectiveness of the vaccine in this age group by the MHRA and the Government’s independent advisory body, the Commission on Human Medicines (CHM). Over 2,000 children aged 12-15 years were studied as part of the randomised, placebo-controlled clinical trials. There were no cases of COVID-19 from 7 days after the second dose in the vaccinated group, compared with 16 cases in the placebo group. In addition, data on neutralising antibodies showed the vaccine working at the same level as seen in adults aged 16-25 years. No new side effects were identified and the safety data in children was comparable with that seen in young adults. As in young adults, the majority of adverse events were mild to moderate and relating to reactogenicity, such as a sore arm or tiredness.

    Any vaccine must first go through the usual rigorous testing and development process and meet strict standards of safety, quality and effectiveness before it can be deployed. There are extensive checks and balances at every stage of the development of a vaccine. The data looked at includes all the results from laboratory studies, clinical trials, manufacturing and quality controls and testing of the product. The public should be very confident that all tests are completed to the very highest standards.

    For all vaccines authorised for supply in the UK, including COVID-19 vaccines, each candidate is assessed by teams of scientists and clinicians on a case by case basis and is only authorised once it has met robust standards of effectiveness, safety and quality set by MHRA.

    Once a vaccine is approved for use in the UK, the Joint Committee on Vaccination and Immunisation (JCVI), an independent body made up of scientific and clinical experts, will provide advice to the Government on which safe, effective vaccines to use, and advise on prioritisation at a population level. The committee’s membership is made up of public health and scientific experts who have considered and continue to consider the impact of COVID-19 and population prioritisation as new data emerges.

    Now that the Pfizer/BioNTech vaccine has been authorised for use in children aged 12-15 in the UK, we will be guided by the advice of experts, including the JCVI, on any potential deployment of COVID-19 vaccination in children under the age of 18.

    No decisions have been made by the Government on the routine COVID-19 vaccination of children. In line with the advice of the JCVI for Phase One of the vaccination programme, children/young adults aged 16-18 could be offered a vaccine if they have an underlying condition that put them at increased risk from COVID-19. However, the JCVI currently advises that children under 16 years of age, even if they are clinically extremely vulnerable (CEV), are at low risk of serious morbidity and mortality and given the absence of safety and efficacy data on COVID-19 vaccines, are not currently recommended for routine COVID-19 vaccination.

    Following infection, almost all children will also have asymptomatic infection or mild disease. Therefore, only children under 16 who are at very high risk of exposure and serious outcomes, such as those with severe neuro-disabilities that require residential care, may be considered for a COVID-19 vaccination. This is given the very high risk of exposure to infection and outbreaks in residential settings. Decisions to vaccinate such children should be made on a case by case basis, with consultation taking place between clinicians, parents/carers and children. The MHRA updated its authorisation guidance in relation to the currently approved vaccines in February to allow this approach.

    The JCVI continues to look at the emerging evidence on COVID-19, and will offer further advice to the Government if and when evidence is found that routinely vaccinating children under 18 years old would further reduce overall mortality, morbidity and hospitalisation which is the overarching objective of the COVID-19 vaccination programme.

    Department for Health and Social Care
    Last edited by Myristyl; 8th June 2021 at 12:54. Reason: Petition is still open not closed as I put before

  2. The Following 9 Users Say Thank You to Myristyl For This Post:

    Bill Ryan (8th June 2021), Chris Gilbert (8th June 2021), Gwin Ru (8th June 2021), Ioneo (8th June 2021), Karen (Geophyz) (8th June 2021), Tintin (8th June 2021), toppy (9th June 2021), Victoria (9th June 2021), wondering (8th June 2021)

  3. Link to Post #2
    United States Avalon Member
    Join Date
    25th March 2010
    Location
    Northern Michigan
    Age
    61
    Posts
    2,254
    Thanks
    8,499
    Thanked 18,724 times in 2,088 posts

    Default Re: Petition: “Do not vaccinate children against COVID-19 until Phase 3 trials are complete”

    Would have been nice if they would have just responded " No children under the age of 18 will be receiving any shots period.". And that we will continue to experiment on the general population for the foreseeable future.

  4. The Following 5 Users Say Thank You to pyrangello For This Post:

    Karen (Geophyz) (8th June 2021), Myristyl (11th June 2021), Tintin (8th June 2021), Victoria (9th June 2021), wondering (8th June 2021)

+ Reply to Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts